Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 29, 2003 - Issue 5
Submit an article Journal homepage
115
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Development of Modified Release Diltiazem HCl Tablets Using Composite Index to Identify Optimal Formulation

M. C. Gohel Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Navrangpura, Ahmedabad, India
,
M. M. Patel Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat Vidyanagar, India
&
A. F. Amin Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat Vidyanagar, India
Pages 565-574 | Published online: 05 Dec 2003

References

  • Jain N.K., Kulkarni K., Talwar N. Controlled release tablet formulation of isoniazid. Pharmazie 1992; 47(4)277–278
  • Gohel M.C., Jani G.K., Patel N.K., Gondaliya D.P. Optimisation of hydrophilic matrix tablet formulation of diclofenac sodium using a mixture design. Pharm. Pharmacol. Comm. 1998; 4(9)433–438
  • Gohel M.C., Patel K.V. Formulation optimisation of diltiazem-HCl matrix tablets containing modified ispaghula husk using factorial design. Drug Dev. Ind. Pharm. 1997; 23(11)1055–1061
  • Gohel M.C., Amin A.F., Chhabaria M.T., Panchal M.K., Lalwani Anita. Modulation of drug release rate of diltiazem-HCl from hydrogel matrices of succinic acid-treated ispaghula husk. Pharm. Dev. Technol. 2000; 5(3)375–381
  • Khullar P., Khar R.K., Agrawal S.P. Evaluation of hydrogel-based controlled-release niacin tablets. Drug Dev. Ind. Pharm. 1998; 24(5)479–483
  • Kuhrts E.H., Friend D.R., Parasrampuria K.Yu.J. Sustained release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants. PCT Int. Appl. WO96 1996; 16: 638
  • Bhalla H.L., Shah A.A. Controlled release matrices for ketoprofen. Indian Drugs 1991; 28(9)420–422
  • Jain N.K., Kulkarni K., Talwar N. Controlled-release tablet formulation of isoniazid. Pharmazie 1992; 47(4)277–278
  • Misra A.N., Baweja J.M. Modified guar gum as hydrophilic matrix for controlled release tablets. Indian Drugs 1997; 34(4)216–223
  • Gohel M.C., Amin A.F., Panchal M.K., Momin M., Bajaj S., Lalwani A. Preliminary investigation in matrix based tablet formulation of diclofenac sodium containing succinic acid treated guar gum. Boll. Chim. Farm. 1998; 137(6)198–203
  • Khan M.Z.I. Recent trends and progress in sustained or controlled oral delivery of some water-soluble drugs: morphine salts, diltiazem and captopril. Drug Dev. Ind. Pharm. 1995; 21(9)1037–1070
  • Venkatesh G.M. Development of controlled release SK & F 82526-J, buffer bead formulations with tartaric acid as a buffer. Pharm. Dev. Technol. 1998; 3: 477–485
  • Gabr K.E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm. 1992; 38: 199–202
  • Gohel M.C., Patel M.M. Release rate modulation of diltiazem HCl from hydrophilic matrix of tartaric acid treated guar gum. Int. J. Pharm. Excipients 2001; 3(2)39–45
  • Salsa T., Veiga F., Pina M.E. Drug Dev. Ind. Pharm. 1997; 23(9)929–938
  • Shah V.P., Tsong Y., Sathe P., Liu J. In vitro dissolution comparison—statistics and analysis of the similarity factor, f2. Pharm. Res. 1998; 15(6)889–896
  • Derringer G., Suich R. Simultaneous optimization of several response variables. Journal of Quality Technology 1980; 12(4)214–219
  • Bodea A., Leucuta S.E. Drug Dev. Ind. Pharm. 1998; 24(2)145–155
  • Robert Lu D., Abu-Izza K., Chen W. Pharm. Tech. 1996; 1(4)405–414
  • Wang Y. Min., Sato H., Adachi I., Horikoshi I. J. Pharm. Sci. 1996; 85(11)1204–1210
  • Shigeo O., Toshihiko K., Yousuke M., Masaharn M., Hiroshima S., Kozo T., Nagai T. J. Pharm. Sci. 1994; 83(3)439–443
  • Taylor M., Ginsburg J., Hickey A., Gheyas F. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. Pharm. Sci. Tech. 2000; 1(3)18
  • Bamba M., Puisieusx F. Int. J. Pharm. 1979; 2: 307–315
  • Peck G.E., Johnson A.D., Aderson V.L. A statistical approach for the development of an oral controlled-release matrix tablets. Pharm. Res. 1990; 7: 1092–1097

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.